Sign in

BJUI Knowledge

@bjuiknowledge.bsky.social
229 followers 321 following 82 posts

BJUI Knowledge is the eLearning platform for urologists and all those with an interest in urology practice, to support their ongoing education and deliver the best patient care. www.bjuinternational.com

PostsRepliesMedia
BJUI Knowledge @bjuiknowledge.bsky.social · 30/09/2026
📢 Join BJUI Section Editor Thomas Kessler at the 49th Annual Scientific Meeting of the Indonesian Urological Association for practical insights on research, publishing, and increasing your impact. 📆 2 October📍 Imperium 1, 2, 3 🔬 Research and Beyond 🕐 8:00 AM ✍️ Publication 🕐 10:15 AM #ASMIUA2026
010
BJUI Knowledge @bjuiknowledge.bsky.social · 29/09/2026
Supporting The Urology Foundation's 'Worth its Weight in GOLD' campaign this #UrologyAwarenessMonth 💛 Explore our eLearning modules on haematuria, urodynamics and UTIs, and refresh your understanding of urine as a valuable diagnostic and monitoring tool. 📚 bjui.pub/UAM26 #UAM26 #Urology #CPD
010
BJUI Knowledge @bjuiknowledge.bsky.social · 22/09/2026
Looking to refresh your knowledge of #paediatric urology? Complete the updated module on penile plastic operations in childhood and earn #CPD points. It's one of several recently reviewed paediatric modules available on BJUI Knowledge. 🔗 bjui.pub/Paediatric-c... #PaediatricUrology #Urology
010
BJUI Knowledge @bjuiknowledge.bsky.social · 04/09/2026
⏰ One day to go! Don’t miss the BJUI Lecture tomorrow at #UAA2026, featuring @dr-coops.bsky.social, who will explore “Advantages and Dangers of Using Artificial Intelligence for Research.” 📍 Manila 📅 Saturday 5 September 🕗 08:15 We look forward to seeing you there! #Urology #AIinResearch
010
BJUI Knowledge @bjuiknowledge.bsky.social · 04/09/2026
Attending #UAA2026 in Manila this weekend? ✍️ Join the BJUI Scientific Writing Workshop tomorrow, in collaboration with the International Journal of Urology and the Philippine Journal of Urology. 🎤 Meet our BJUI speakers: @dr-coops.bsky.social @sophiaanderton.bsky.social Hope to see you there!
020
BJUI Knowledge @bjuiknowledge.bsky.social · 19/08/2026
🆕 New video: robotic #PLND for penile cancer! Expert urologists demonstrate the technical steps of robotic bilateral pelvic lymph node dissection in a patient with squamous cell carcinoma of the penis. The video highlights key anatomical, oncological & surgical principles 📽️ bjui.pub/PLND #Urology
011
BJUI Knowledge @bjuiknowledge.bsky.social · 28/07/2026
Do you know the procedural steps for #ThuLEP to ensure safe and effective application in clinical practice? Complete the new module to recognise, anticipate, identify, and manage possible intraoperative and postoperative complications associated with ThuLEP. 🔗Gain #CPD points: bjui.pub/NEWThuLEP
010
BJUI Knowledge @bjuiknowledge.bsky.social · 24/06/2026
This #InfertilityAwarenessMonth 🎗️ stay up to date with the latest knowledge, strengthen your clinical practice, and support better outcomes for men facing #infertility. Explore the recently updated module: "Klinefelter syndrome and success of sperm retrieval". bjui.pub/IAM26 #Urology #MensHealth
020
BJUI Knowledge @bjuiknowledge.bsky.social · 16/06/2026
Join the BJUI Guest Lecture at #BAUS26 today! Professor Sir Mike Richards will discuss how the UK NSC developed its prostate cancer screening recommendations and where further evidence is needed. 🕤 9:45am | 📍 Terence Millin #Urology #MedicalConference #ProstateCancer @bjuijournal.bsky.social
010
BJUI Knowledge @bjuiknowledge.bsky.social · 15/06/2026
Attending #BAUS26 this week? The @bjuijournal.bsky.social team would be delighted to welcome you to our exhibition table. Please stop by to say hello, meet the team, and pick up a complimentary BJUI coaster! 📅 15-17 June 📍 Olympia, London 🏢 BJUI Exhibition Table 3️⃣ #Urology #MedicalConference
020
Reposted by BJUI Knowledge
BJUI & BJUI Compass @bjuijournal.bsky.social · 11/06/2026
More harm than good? The UK National Screening Committee's latest review of prostate cancer screening Professor Sir Mike Richards and colleagues describe the process taken by the UK NSC in developing its recommendations and highlight where additional evidence is still needed doi.org/10.1111/bju....
More harm than good? The UK National Screening Committee's latest review of prostate cancer screening
Talia Boshari, Andrew Anderson, Michael Richards

Abstract

Prostate cancer is the most common type of cancer in men but there is no national screening programme in the UK or in most other countries. The UK National Screening Committee (UK NSC) is the independent advisory body responsible for providing evidence-based recommendations to ministers in the four UK nations regarding screening programmes. Following the expansion of its remit to include targeted screening (2022) and the publication of new long-term trial data, the UK NSC launched a comprehensive review of prostate cancer screening in 2025. To inform this review, a bespoke economic model was commissioned, drawing on best available evidence and input from clinicians, technical experts, and patient representatives. The model evaluated whole-population screening and targeted strategies for men at higher risk. Based on the modelling study and consultation with stakeholders, the UK NSC recommended against whole-population screening and screening in most targeted groups. The UK NSC has recommended screening for men with a pathogenic BRCA2 variant with a family history of breast, ovarian, pancreatic, or prostate cancer. This was the only group where the UK NSC had confidence that screening would do more good than harm, primarily because prostate cancer tends to be more aggressive in this group. This narrative review describes the process taken by the UK NSC in developing its recommendations and highlights where additional evidence is still needed.
011
Reposted by BJUI Knowledge
BJUI & BJUI Compass @bjuijournal.bsky.social · 01/06/2026
Online now - Guideline of guidelines: lutetium-177 PSMA radioligand therapy in advanced prostate cancer doi.org/10.1111/bju....
Guideline of guidelines: lutetium-177 PSMA radioligand
therapy in advanced prostate cancerAbstract
Objective
To synthesise current international guidance on lutetium-177-labelled prostate-specific membrane antigen (177Lu-PSMA) radioligand therapy (RLT) across the prostate cancer disease spectrum, with emphasis on metastatic castration-resistant prostate cancer (mCRPC) and emerging earlier-line indications.
Methods
A structured literature overview was conducted. PubMed, EMBASE, and official repositories of major urological, oncological, and nuclear medicine societies were searched from inception to 31 October 2025 for prostate cancer guidelines. National and international guidelines or consensus statements published in English were eligible if they provided explicit recommendations regarding 177Lu-PSMA-RLT in their most recent version. Documents without therapeutic recommendations or superseded by updated versions were excluded. Six major society guidelines were included: European Association of Urology (EAU 2025), American Urological Association/Society of Urologic Oncology (AUA/SUO 2023), National Comprehensive Cancer Network (NCCN 2025), Canadian Urological Association (CUA 2024), American Society of Clinical Oncology (ASCO 2025), and European Society for Medical Oncology (ESMO 2020). The joint European Association of Nuclear Medicine/Society of Nuclear Medicine and Molecular Imaging (EANM/SNMMI 2023) procedural guideline and expert consensus from the Advanced Prostate Cancer Consensus Conference (APCCC 2024) were also reviewed.
Results
All societies except ESMO, which has not yet updated its guidance on PSMA-RLT, endorse 177Lu-PSMA-617 for PSMA-positive mCRPC following prior androgen receptor pathway inhibitor (ARPI) and taxane chemotherapy, supported by Level 1 evidence from the VISION and TheraP trials. Following PSMAfore, NCCN version1.2025, and more cautiously the EAU 2025 guideline, acknowledge expansion into taxane-naïve patients progressing after ARPI therapy. The recommended regimen remains 7.4 GBq every 6 weeks for up to six cycles with concu…
021
Reposted by BJUI Knowledge
Sophia Anderton @sophiaanderton.bsky.social · 30/04/2026
Will you be at AUA in Washington DC? Come to this joint session between @bjuijournal.bsky.social, @usanzurology.bsky.social and BAUS. app.swapcard.com/event/2026-a... #AUA26 #UTI
BAUS-BJUI-USANZ joint session at the AUA
Urinary Tract Infection Management: Answering the Burning Questions
Saturday May 16, 2025, 1-4pm Room 140A
133
Reposted by BJUI Knowledge
BJUI & BJUI Compass @bjuijournal.bsky.social · 14/05/2026
On your way to #AUA26? Please join us for the BAUS-BJUI-USANZ joint session Urinary Tract Infection Management: Answering the Burning Questions Saturday, May 16, 2026 1:00 – 4.00 PM Room 140
Invitation to the BAUS-BJUI-USANZ joint session AUA 26

Urinary Tract Infection Management: Answering the Burning Questions
Saturday, May 16, 2026     1:00 – 4.00 PM 
Room 140
222
BJUI Knowledge @bjuiknowledge.bsky.social · 06/05/2026
🚨 4 new Question Banks now live on BJUI Knowledge! Focused on andrology & infertility, with case-based and MCQ formats to test your skills. 🏆 Pass mark: 80% 🔁 Multiple attempts allowed 📚 Ideal for trainees, exam prep, and continued learning. Test yourself now: bjui.pub/New_QBs #Urology #CME
011
BJUI Knowledge @bjuiknowledge.bsky.social · 18/03/2026
📣 Free to read until 7th April! The BJUI themed issue on Fluid management and Suction in EndoUrology is now available with free access for a limited time. 🔎 Explore the full collection: bjui.pub/SuctionIssue #Urology #EndoUrology #OpenAccess
bjui.pub
Themed Issue: Fluid Management and Suction in Endourology: BJU International: Vol 137, No S3
Click on the title to browse this issue
010
BJUI Knowledge @bjuiknowledge.bsky.social · 12/03/2026
BJUI Editor-in-Chief Freddie Hamdy will be representing BJUI at the 41st Annual EAU Congress this week. 📢 Hear him speak about prostate cancer on the following days: 📆13 March 🕐1 pm 📍Orange Area, Room 3 📆15 March 🕐8 am 📍Orange Area, eURO Auditorium 1 Learn more about the event: bjui.pub/EAU26
010
Reposted by BJUI Knowledge
Sophia Anderton @sophiaanderton.bsky.social · 10/03/2026
I will be at the @uroweb.org EAU meeting in London later this week representing @bjuicompass.bsky.social @bjuijournal.bsky.social. If you're there too let me know if you'd like to meet - would love to see you! #EAU #Urology #Conference
032
Reposted by BJUI Knowledge
USANZ @usanzurology.bsky.social · 02/03/2026
The USANZ Medal is an honour bestowed to a Member who has given exceptional service & leadership over a considerable number of years. The second recipient at #USANZ26 is Nathan Lawrentschuk in recognition for his work editing the USANZ @bjuijournal.bsky.social Supplement.
022
Reposted by BJUI Knowledge
BJUI & BJUI Compass @bjuijournal.bsky.social · 05/03/2026
Thank you to Anne Suskind from UCSF for delivering the BJUI lecture at last week's @usanzurology.bsky.social urology.bsky.social Annual Meeting.
032
BJUI Knowledge @bjuiknowledge.bsky.social · 06/03/2026
March is #KidneyCancerAwarenessMonth 🎗 To support awareness and ongoing professional development this month, we’re offering free access to a taster module from our curriculum: “When is active surveillance for the small renal mass appropriate?” 👉 bjui.pub/KCAM26 #Urology #KCAM #KidneyCancer #CPD
010
Reposted by BJUI Knowledge
Wiley Clinical and Health @wileyhealth.bsky.social · 09/02/2026
‘BJUI Clinical Dilemma’: the overactive bladder has been selected as the Editor's Choice article for Feb 2026. Don't miss out on reading this Open Access article: ow.ly/9S4P50Y9Pu7
032
Reposted by BJUI Knowledge
USANZ @usanzurology.bsky.social · 01/03/2026
Congratulations to Nicholas Brown, who has won the BJUI Global Prize 2026 for his article on the P-EASY ADVANCE trial. The award was presented at #USANZ26 by @bjuijournal.bsky.social, Editor-in-Chief Freddie Hamdy
032
Reposted by BJUI Knowledge
USANZ @usanzurology.bsky.social · 01/03/2026
A joint USANZ and @bjuijournal.bsky.social Plenary at #USANZ26. The session opened with a highlight of the BJUI - USANZ Supplement, led by the incoming co-editors, USANZ Members Matt Roberts and Marlon Perera
032
BJUI Knowledge @bjuiknowledge.bsky.social · 17/02/2026
Our latest module, "Bridging the gap: navigating the transition to registrar in urology", explores the key challenges of this progression - including the structure and expectations of non-resident on-call responsibilities in urology 🎓 Discover more here👉 bjui.pub/Bridging-the... #Urology #CPD #CME
010
BJUI Knowledge @bjuiknowledge.bsky.social · 04/02/2026
This #WorldCancerDay, explore our multimedia content in urological #oncology covering all six urological cancer types - bladder, kidney, prostate, penile, testicular, and upper tract. Designed to support #CPD and deepen clinical understanding. 🔗 Learn more: bjui.pub/WorldCancerDay #Urology
010
BJUI Knowledge @bjuiknowledge.bsky.social · 28/01/2026
BJUI Trustee John McGrath will be representing BJUI in India at USICON this week. 📢 Hear him speak about the decarbonisation of urological care pathways on 31 January at 11 am in Hall H. Learn more about the event: bjui.pub/USICON2026 #USICON2026
010
BJUI Knowledge @bjuiknowledge.bsky.social · 27/01/2026
🆕Urologists perform direct vascular renal pedicle access through the mesocolic root, which can reduce extensive mobilisation of the colon. This approach reduces operative time & blood loss, and allows for early pedicle control, making the tumour relatively avascular. 📽️Watch now: bjui.pub/RNvideo
010
BJUI Knowledge @bjuiknowledge.bsky.social · 14/01/2026
📽️ New procedural video on #MiniPCNL Explore the technical steps of mini-PCNL - a minimally invasive surgical procedure for kidney stone removal, using a 14–20Fr access sheath. Watch to see the key procedural steps in action 👉 bjui.pub/mini-PCNL #Urology #KidneyStones #Endourology
020
BJUI Knowledge @bjuiknowledge.bsky.social · 23/12/2025
Season’s Greetings from all of us at BJUI!🎄 We would like to thank our urology community and subscribers for your continued support and engagement throughout the year. The BJUI office will be closed 25-26 December and 1-2 January. We wish you a restful festive season and a successful year ahead!
010
Reposted by BJUI Knowledge
BJUI & BJUI Compass @bjuijournal.bsky.social · 16/12/2025
Podcast: The BAUS Consensus document for the management of male genital emergencies: priapism Part of the BJUI/BURST podcast series. @bursturology.bsky.social www.bjuinternational.com/bjui-burst-t...
bjuinternational.com
BJUI/BURST: BAUS consensus document for the management of male genital emergencies: priapism - BJUI
Podcast discussing the BAUS Consensus document for the management of male genital emergencies: priapism.
024
BJUI Knowledge @bjuiknowledge.bsky.social · 19/11/2025
This #InternationalMensDay, we are highlighting the importance of men’s urological health 💙 Explore the diagnosis, treatment, and clinical insights on prostate and testicular cancer, BPH, ED, and other urology concerns through our curated content on men's urological health: bjui.pub/IMD25 #IMD2025
030
BJUI Knowledge @bjuiknowledge.bsky.social · 18/11/2025
This #Movember, we’re highlighting Prostate Cancer - the most common cancer in men. To support awareness and education, we’re providing free access to a taster module from our curriculum: “Essentials of cryotherapy in prostate cancer.” 👉 bjui.pub/movember #Urology #MensHealth #ProstateCancer
030
Reposted by BJUI Knowledge
BJUI & BJUI Compass @bjuijournal.bsky.social · 04/11/2025
Outcomes in PCT after short-term AAS use were analyzed in recreational bodybuilders. 🌟 89.9% had ED; 69.7% had azoospermia. 📈 87.5% normozoospermia with CC+hCG by 12 months. 🔬 Testicular increase of ≥20% in 70.8% with CC+hCG. #AAS #PCT #Bodybuilding #SteroidUse #ReproductiveHealth tnyp.me/sMbuw8xL
tnyp.me
Post‐cycle therapy after short‐term anabolic‐androgenic steroid use: comparative outcomes in recreational bodybuilders
Objectives To evaluate the clinical necessity and optimal pharmacological strategy for post-cycle therapy (PCT) in recreational anabolic-androgenic steroid (AAS) users with normal pre-cycle reproduc...
021
Reposted by BJUI Knowledge
BJUI & BJUI Compass @bjuijournal.bsky.social · 31/10/2025
BJUI Charity Chair, Alan McNeill, and Urological Society of India President, Rajeev T P, today signed a new affiliation agreement between the two organisations at this week's SIU meeting in Edinburgh.
Alan McNeill and Rajeev TP
021
BJUI Knowledge @bjuiknowledge.bsky.social · 31/10/2025
👻 This Halloween, beware the real BOO - Bladder Outlet Obstruction! 💊 Dive deeper into the mechanism of action behind the ability of alpha blockers to improve #BOO and #LUTS in our eLearning module: 'Update on alpha-blocker monotherapy in LUTS'. 👉 bjui.pub/4ofXS69 #Urology #CPD #HappyHalloween
010
BJUI Knowledge @bjuiknowledge.bsky.social · 29/10/2025
🚨 New Question Banks! 🚨 6 new Question Banks now available on BJUI Knowledge, covering: 🟧 Kidney Cancer 🟧 Penile Cancer 🟧 Reconstructive Urology 📚 Ideal for trainees, exam prep, and continued learning. Test yourself now 👉 bjui.pub/New-QBs #Urology #CME #CPD #QuestionBank
010
Reposted by BJUI Knowledge
BJUI & BJUI Compass @bjuijournal.bsky.social · 28/10/2025
The impact of multiparametric MRI and biopsies on anxiety and quality of life: 🔍 No differences in anxiety scores 📉 Lower incontinence and hormonal symptom scores after 6 months 📊 626 biopsy-naïve patients studied tnyp.me/yuxG6fq0 #MRI #ProstateCancer #HRQoL #Pub2Post
tnyp.me
Impact of multiparametric MRI and prostate biopsies on anxiety and quality of life in men with suspected prostate cancer
Objectives To study the impact of the new MRI pathway and conventional transrectal ultrasound-guided systematic biopsies (TRUSGB) on anxiety and HRQoL in men with suspected PCa. Materials and meth...
011
Reposted by BJUI Knowledge
BJUI & BJUI Compass @bjuijournal.bsky.social · 23/10/2025
Hugo RAS System in Multicentre RAPN 🦾 Tetrafacta was achieved in 80% of cases. 🏥 Post-op complications: 20.7%, with 5% major. ⏱ Median operative time: 150 minutes. Read the article: tnyp.me/82mBF0XA #KidneyCancer#Nephrectomy #Surgery #Urology #Pub2Post
tnyp.me
Robot‐assisted partial nephrectomy using the Hugo™ RAS System: first multicentre study and Tetrafecta achievement
Objective To evaluate the perioperative outcomes and the rate of Tetrafecta achievement in robot-assisted partial nephrectomy (RAPN) cases performed using the Hugo™ robot-assisted surgery (RAS) syst...
121
Reposted by BJUI Knowledge
BJUI & BJUI Compass @bjuijournal.bsky.social · 24/10/2025
Long-term outcomes of cascading salvage therapy for HR-NMIBC: 🚀 5-year PFS: 81% 🔄 2-year RFS: 47% (1st), 43% (2nd), 39% (3rd line) 🔬 Multi-line BST: Viable alternative to RC Read the article here tnyp.me/4YMQ4DVT #BladderCancer #Oncology #BST #Pub2Post
011
BJUI Knowledge @bjuiknowledge.bsky.social · 22/10/2025
📽️ Watch our latest video for insights into safe and efficient #RPRN technique: bjui.pub/RPRN 🤖 Covering: 🔹 Retroperitoneal access 🔹 Mobilising upper pole & hilum dissection 🔹 Dissection of renal artery & vein 🔹 Adrenal preservation 🔹 Ureter separation & kidney mobilisation. #Urology #Nephrectomy
010
Reposted by BJUI Knowledge
BJUI & BJUI Compass @bjuijournal.bsky.social · 09/10/2025
BJU International Charity Chair, Alan McNeill, presenting at the CAU congress in Panama this week.
BJU International Charity Chair, Alan McNeill, presenting at the CAU congress in Panama this week.
031
Reposted by BJUI Knowledge
BJUI & BJUI Compass @bjuijournal.bsky.social · 16/09/2025
Podcast: The BAUS Consensus Statement on Ketamine Uropathy Part of the BJUI/BURST podcast series. @bursturology.bsky.social bjui.pub/4ph2Xfo
BJUI BURST podcast series logo
032
BJUI Knowledge @bjuiknowledge.bsky.social · 16/09/2025
🚨 Updated Modules in Oncology 🚨 🎯 Upper Tract Cancer: Explore the latest on focal therapy for upper urinary tract tumors 👉 bjui.pub/oncology1 🧬 Prostate Cancer: Understand the evolving role of surgery in T3 prostate cancer 👉 bjui.pub/oncology2 #Oncology #UpperTractCancer #ProstateCancer #Urology
020
BJUI Knowledge @bjuiknowledge.bsky.social · 09/09/2025
This #UrologyAwarenessMonth, we’re supporting The Urology Foundation to raise awareness of #BladderLeakage - a common condition affecting 1 in 3 women in the UK. 🟠🟣🟠 Get FREE access to our taster module: Reasons Behind Female Bladder Dysfunction 👉 bjui.pub/Free-Taster #UAM25 #Urology #TUF
032
BJUI Knowledge @bjuiknowledge.bsky.social · 03/09/2025
#UrologyAwarenessMonth is here! 💜 This September, we're highlighting Bladder Leakage - a condition affecting millions across the UK. From #OAB to urge and stress #incontinence and more, explore the causes and clinical insights with our curated modules on #BladderLeakage 👉 bjui.pub/UAM25 #UAM25
020
BJUI Knowledge @bjuiknowledge.bsky.social · 26/08/2025
🚨 Free eLearning 🚨 Marking 10 years of the GIBS Congress on IC/BPS this month, get free access to our bite-size eLearning on the O'Leary-Sant score – a key assessment tool in the diagnosis of #IC/BPS. 🎯 For urologists, pelvic pain specialists, nurses & trainees. 👉 bjui.pub/FreeQC #Urology #CME
010
BJUI Knowledge @bjuiknowledge.bsky.social · 19/08/2025
Boost your team’s learning – together! 👥 Group access from £5/mo* for 5-10 users. Clinical teams, small orgs & specialists get: ✅ 450+ eLearning modules ✅ Certificates & #CPD tracking ✅ #OA to all BJUI Compass articles & more! *Price varies by location/group size. 📝 Subscribe: bjui.pub/Group
020
BJUI Knowledge @bjuiknowledge.bsky.social · 05/08/2025
🔓 7 #OpenAccess articles featured in the August issue of BJUI!
020
BJUI Knowledge @bjuiknowledge.bsky.social · 05/08/2025
🧠 New #BPH & #LUTS Question Bank Perfect for FRCS (Urol) exam prep and day-to-day learning. 📚 Featuring: ✔️ Clinical case studies ✔️ SBAs & MCQs ✔️ Evidence-based explanations ✔️ Focused on real-world decision making 📲 Start now: bjui.pub/BPH-LUTS4
010